Urecholine

A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Urecholine is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, cardiac rate changes, and bronchial spasms. .
[PubChem].

Medicinal name:
  • Bethanechol Chloride 5 MG Oral Tablet [Urecholine]
  • Bethanechol Chloride 25 MG Oral Tablet [Urecholine]
  • Bethanechol Chloride 50 MG Oral Tablet [Urecholine]
  • Bethanechol Chloride 10 MG Oral Tablet [Urecholine]

Urecholine - Pharmacology:

Urecholine acts by selectively stimulating muscarinic receptors in the parasympathetic nervous system, inducing no affect on nicotinic receptors.

Urecholine mini report

Urecholine ANDA
ANDA - A product marketed under an approved Abbreviated New Drug Application
Urecholine HUMAN PRESCRIPTION DRUG
HUMAN PRESCRIPTION DRUG
Start - Stop data
START DATA:
2000-Apr-01
Start - Stop data
STOP DATA
not occurred

Urecholine for patients

Urecholine chloride tablets should preferably be taken one hour before or two hours after meals to avoid nausea or vomiting. Dizziness, lightheadedness or fainting may occur, especially when getting up from a lying or sitting position.

Urecholine Interactions

Special care is required if this drug is given to patients receiving ganglion blocking compounds because a critical fall in blood pressure may occur. Usually, severe abdominal symptoms appear before there is such a fall in the blood pressure.

Urecholine Contraindications

Hypersensitivity to bethanechol chloride tablets, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy, and parkinsonism.

Urecholine chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia.

Manufacturers name:

  • Teva Womens Health, Inc

Generic name, Overdose, Half Life Urecholine, Food Interactions, Chemical, etc..

Urecholine see also FDA report

Brand Names containing Bethanechol